Boston Millennia Partners Intends to Vote Against Proposed Merger of SomaLogic With Standard BioTools

Boston Millennia Partners (“Boston Millennia”), a significant shareholder of SomaLogic (the “Company”) (Nasdaq: SLGC) today announced that it intends to vote against the Company’s planned merger (the “Merger”) with Standard BioTools Inc. (Nasdaq: LAB).

View source version on businesswire.com: https://www.businesswire.com/news/home/20231231077712/en/